Literature DB >> 24986662

Stereochemical modification of geminal dialkyl substituents on pantothenamides alters antimicrobial activity.

Annabelle Hoegl1, Hamed Darabi1, Elisa Tran1, Emelia Awuah1, Eleanor S C Kerdo2, Eric Habib1, Kevin J Saliba3, Karine Auclair4.   

Abstract

Pantothenamides are N-substituted pantothenate derivatives which are known to exert antimicrobial activity through interference with coenzyme A (CoA) biosynthesis or downstream CoA-utilizing proteins. A previous report has shown that replacement of the ProR methyl group of the benchmark N-pentylpantothenamide with an allyl group (R-anti configuration) yielded one of the most potent antibacterial pantothenamides reported so far (MIC of 3.2 μM for both sensitive and resistant Staphylococcus aureus). We describe herein a synthetic route for accessing the corresponding R-syn diastereomer using a key diastereoselective reduction with Baker's yeast, and report on the scope of this reaction for modified systems. Interestingly, whilst the R-anti diastereomer is the only one to show antibacterial activity, the R-syn isomer proved to be significantly more potent against the malaria parasite (IC50 of 2.4±0.2 μM). Our research underlines the striking influence that stereochemistry has on the biological activity of pantothenamides, and may find utility in the study of various CoA-utilizing systems.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Antibacterial; Antiplasmodial; Baker’s yeast; Coenzyme A; Pantothenamides

Mesh:

Substances:

Year:  2014        PMID: 24986662      PMCID: PMC5226837          DOI: 10.1016/j.bmcl.2014.06.013

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  20 in total

1.  Inhibitors of aminoglycoside resistance activated in cells.

Authors:  Kenward Vong; Ingrid S Tam; Xuxu Yan; Karine Auclair
Journal:  ACS Chem Biol       Date:  2012-01-18       Impact factor: 5.100

2.  CJ-15,801, a fungal natural product, inhibits the intraerythrocytic stage of Plasmodium falciparum in vitro via an effect on pantothenic acid utilisation.

Authors:  Kevin J Saliba; Kiaran Kirk
Journal:  Mol Biochem Parasitol       Date:  2005-05       Impact factor: 1.759

3.  One-pot chemo-enzymatic synthesis of reporter-modified proteins.

Authors:  Andrew S Worthington; Michael D Burkart
Journal:  Org Biomol Chem       Date:  2005-11-24       Impact factor: 3.876

4.  In vivo reporter labeling of proteins via metabolic delivery of coenzyme A analogues.

Authors:  Kristine M Clarke; Andrew C Mercer; James J La Clair; Michael D Burkart
Journal:  J Am Chem Soc       Date:  2005-08-17       Impact factor: 15.419

5.  A class of pantothenic acid analogs inhibits Plasmodium falciparum pantothenate kinase and represses the proliferation of malaria parasites.

Authors:  Christina Spry; Christina L L Chai; Kiaran Kirk; Kevin J Saliba
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

6.  Provitamin B5 (pantothenol) inhibits growth of the intraerythrocytic malaria parasite.

Authors:  Kevin J Saliba; Isabelle Ferru; Kiaran Kirk
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

7.  From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways.

Authors:  Svetlana Y Gerdes; Michael D Scholle; Mark D'Souza; Axel Bernal; Mark V Baev; Michael Farrell; Oleg V Kurnasov; Matthew D Daugherty; Faika Mseeh; Boris M Polanuyer; John W Campbell; Shubha Anantha; Konstantin Y Shatalin; Shamim A K Chowdhury; Michael Y Fonstein; Andrei L Osterman
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

8.  Acyl carrier protein is a cellular target for the antibacterial action of the pantothenamide class of pantothenate antimetabolites.

Authors:  Yong-Mei Zhang; Matthew W Frank; Kristopher G Virga; Richard E Lee; Charles O Rock; Suzanne Jackowski
Journal:  J Biol Chem       Date:  2004-09-30       Impact factor: 5.157

Review 9.  Coenzyme A biosynthesis: an antimicrobial drug target.

Authors:  Christina Spry; Kiaran Kirk; Kevin J Saliba
Journal:  FEMS Microbiol Rev       Date:  2008-01       Impact factor: 16.408

10.  Antibacterial activity of N-pentylpantothenamide is due to inhibition of coenzyme a synthesis.

Authors:  Jacob Thomas; John E Cronan
Journal:  Antimicrob Agents Chemother       Date:  2010-01-04       Impact factor: 5.191

View more
  5 in total

1.  A pantetheinase-resistant pantothenamide with potent, on-target, and selective antiplasmodial activity.

Authors:  Cristiano J Macuamule; Erick T Tjhin; Collins E Jana; Leanne Barnard; Lizbé Koekemoer; Marianne de Villiers; Kevin J Saliba; Erick Strauss
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

2.  Triazole Substitution of a Labile Amide Bond Stabilizes Pantothenamides and Improves Their Antiplasmodial Potency.

Authors:  Vanessa M Howieson; Elisa Tran; Annabelle Hoegl; Han Ling Fam; Jonathan Fu; Kate Sivonen; Xiao Xuan Li; Karine Auclair; Kevin J Saliba
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

3.  Stable pantothenamide bioisosteres: novel antibiotics for Gram-positive bacteria.

Authors:  Patrick A M Jansen; Danique A van der Krieken; Peter N M Botman; Richard H Blaauw; Lorenzo Cavina; Eline M Raaijmakers; Erik de Heuvel; Julia Sandrock; Lian J Pennings; Pedro H H Hermkens; Patrick L J M Zeeuwen; Floris P J T Rutjes; Joost Schalkwijk
Journal:  J Antibiot (Tokyo)       Date:  2019-06-06       Impact factor: 2.649

Review 4.  The Pathophysiological Role of CoA.

Authors:  Aleksandra Czumaj; Sylwia Szrok-Jurga; Areta Hebanowska; Jacek Turyn; Julian Swierczynski; Tomasz Sledzinski; Ewa Stelmanska
Journal:  Int J Mol Sci       Date:  2020-11-28       Impact factor: 5.923

5.  A cross-metathesis approach to novel pantothenamide derivatives.

Authors:  Jinming Guan; Matthew Hachey; Lekha Puri; Vanessa Howieson; Kevin J Saliba; Karine Auclair
Journal:  Beilstein J Org Chem       Date:  2016-05-13       Impact factor: 2.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.